A U.S. federal appeals court said Regeneron Pharmaceuticals and partner Sanofi can continue selling their cholesterol drug, dealing a blow to rival Amgen, which had accused the companies of violating its patents.
from WSJ.com: US Business http://ift.tt/2xWoKzD
via IFTTT
No comments:
Post a Comment